Tocotrienols and atherosclerosis

Journal of Clinical Biochemistry and Nutrition

Volumn 34, Issue 3, 2004, Pages 121-128

  Naito, Yuji ^a   Shimozawa, Makoto ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Adhesion molecule; Atherosclerosis; Tocopherol; Tocotrienol

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOTRIENOL; CELL ADHESION MOLECULE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; ENDOTHELIUM CELL; ENZYME INHIBITION; FOAM CELL; LIPID OXIDATION; MONOCYTE; NONHUMAN; REVIEW;

EID: 4744369169     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.34.121     Document Type: Review

References (40)

1. Steinberg, D.: Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem., 272, 20963-20966, 1997.
2. Yoshikawa, T., Yoshida, N., Manabe, H., Terasawa, Y., Takemura, T., and Kondo, M.: α-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. BioFactors, 7, 15-19, 1998.
3. Yoshida, N., Manabe, H., Terasawa, Y., Nishimura, H., Enjo, F., Nishino, H., and Yoshikawa, T.: Inhibitory effects of vitamin E on endothelial-dependent adhesive interactions with leukocytes induced by oxidized low density lipoprotein. BioFactors, 13, 279-288, 2000.
4. Terasawa, Y., Manabe, H., Yoshida, N., Uemura, M., Sugimoto, N., Naito, Y., Yoshikawa, T., and Kondo, M.: α-Tocopherol protects against monocyte Mac-1 (CD11b/CD18) expression and Mac-1-dependent adhesion to endothelial cells induced by oxidized low-density lipoprotein. BioFactors, 11, 221-233, 2000.
5. Hodis, H.N., Mack, W.J., LaBree, L., Mahrer, P.R., Sevanian, A., Liu, C.R., Liu, C.H., Hwang, J., Selzer, R.H., and Azen, S.P.: α-Tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation, 106, 1453-1459, 2002.
6. Serbinova, E., Kagan, V., Han, D., and Packer, L.: Free radical recycling and intramembrane mobility in the antioxidant properties of α-tocopherol and α-tocotrienol. Free Radic. Biol. Med., 10, 263-275, 1991.
7. Theriault, A., Chao, J.T., and Gapor, A.: Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. Atherosclerosis, 160, 21-30, 2002.
8. Noguchi, N., Hanyu, R., Nonaka, A., Okimoto, Y., and Kodama, T.: Inhibition of THP-1 cell adhesion to endothelial cells by α-tocopherol and α-tocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic. Biol. Med., 34, 1614-1620, 2003.
9. Khanna, S., Roy, S., Ryu, H., Bahadduri, P., Swaan, P.W., Ratan, R.R., and Sen, C.K.: Molecular basis of vitamin E action. Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J. Biol. Chem., 278, 43508-43515, 2003.
10. Yla-Herttuala, S.: Oxidized LDL and atherogenesis. Ann. N. Y. Acad. Sci., 874, 134-137, 1999.
11. Parthasarathy, S., Young, S.G., Witztum, J.L., Pittman, R.C., and Steinberg, D.: Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest., 77, 641-644, 1986.
12. Liao, L., Starzyk, R.M., and Granger, D.N.: Molecular determinants of oxidized low-density lipoprotein-induced leukocyte adhesion and microvascular dysfunction. Arterioscler. Thromb. Vasc. Biol., 17, 437-444, 1997.
13. O'Neill, T.P.: Apolipoprotein E-deficient mouse model of human atherosclerosis. Toxicol. Pathol., 25, 20-21, 1997.
14. Collins, R.G., Velji, R., Guevara, N.V., Hicks, M.J., Chan, L., and Beaudet, A.L.: P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J. Exp. Med., 191, 189-194, 2000.
15. Zibara, K., Chignier, E., Covacho, C., Poston, R., Canard, G., Hardy, P., and McGregor, J.: Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient compared with wild-type mice. Arterioscler. Thromb. Vasc. Biol., 20, 2288-2296, 2000.
16. Hayek, T., Fuhrman, B., Vaya, J., Rosenblat, M., Belinky, P., Coleman, R., Elis, A., and Aviram, M.: Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol., 17, 2744-2752, 1997.
17. Ni, W., Tsuda, Y., Sakono, M., and Imaizumi, K.: Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. J. Nutr., 128, 1884-1889, 1998.
18. Ormrod, D.J., Holmes, C.C., and Miller, T.E.: Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis, 138, 329-334, 1998.
19. Asset, G., Bauge, E., Wolff, R.L., Fruchart, J.C., and Dallongeville, J.: Pinus pinaster oil affects lipoprotein metabolism in apolipoprotein E-deficient mice. J. Nutr., 129, 1972-1978, 1999.
20. Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., Hayek, T., Presser, D., and Fuhrman, B.: Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr., 71, 1062-1076, 2000.
21. Fuhrman, B., Rosenblat, M., Hayek, T., Coleman, R., and Aviram, M.: Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J. Nutr., 130, 1124-1131, 2000.
22. Naito, Y., Oka, S., and Yoshikawa, T.: Inflammatory response in the pathogenesis of atherosclerosis and its prevention by rosmarinic acid, a functional ingredient of rosemary, in Food Factors in Health Promotion and Disease Prevention, ed. by Shahidi, F., Ho, C.-T., Watanabe, S., and Osawa, T., Washington, ACS, pp. 208-212, 2003.
23. Theriault, A., Chao, J.T., Wang, Q., Gapor, A., and Adeli, K.: Tocotrienol: a review of its therapeutic potential. Clin. Biochem., 32, 309-319, 1999.
24. Heinonen, M. and Piironen, V.: The tocopherol, tocotrienol, and vitamin E content of the average Finnish diet. Int. J. Vitam. Nutr. Res., 61, 27-32, 1991.
25. Packer, L., Weber, S.U., and Rimbach, G.: Molecular aspects of α-tocotrienol antioxidant action and cell signalling. J. Nutr., 131, 369S-373S, 2001.
26. Yoshida, Y., Niki, E., and Noguchi, N.: Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem. Phys. Lipids, 123, 63-75, 2003.
27. +/- mice from diet-induced atheroma formation. J. Nutr., 130, 2420-2426, 2000.
28. Qureshi, A.A., Salser, W.A., Parmar, R., and Emeson, E.E.: Novel tocotrienols of rice bran inhibit atherosclerotic lesions in C57BL/6 ApoE-deficient mice. J. Nutr., 131, 2606-2618, 2001.
29. Qureshi, A.A., Peterson, D.M., Hasler-Rapacz, J.O., and Rapacz, J.: Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. J. Nutr., 131, 223-230, 2001.
30. Parker, R.A., Pearce, B.C., Clark, R.W., Gordon, D.A., and Wright, J.J.: Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem., 268, 11230-11238, 1993.
31. Qureshi, A.A., Mo, H., Packer, L., and Peterson, D.M.: Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties. J. Agric. Food Chem., 48, 3130-3140, 2000.
32. 2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am. J. Clin. Nutr., 53, 1042S-1046S, 1991.
33. Watkins, T., Lenz, P., Gapor, A., Struck, M., Tomeo, A., and Bierenbaum, M.: γ-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Lipids, 28, 1113-1118, 1993.
34. Qureshi, A.A., Bradlow, B.A., Brace, L., Manganello, J., Peterson, D.M., Pearce, B.C., Wright, J.J., Gapor, A., and Elson, C.E.: Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids, 30, 1171-1177, 1995.
35. Qureshi, A.A., Pearce, B.C., Nor, R.M., Gapor, A., Peterson, D.M., and Elson, C.E.: Dietary α-tocopherol attenuates the impact of γ-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J. Nutr., 126, 389-394, 1996.
36. Mensink, R.P., van Houwelingen, A.C., Kromhout, D., and Hornstra, G.: A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am. J. Clin. Nutr., 69, 213-219, 1999.
37. Qureshi, A.A., Bradlow, B.A., Salser, W.A., and Brace, L.D.: Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. Nutr. Biochem., 8, 290-298, 1997.
38. Chao, J.T., Gapor, A., and Theriault, A.: Inhibitory effect of δ-tocotrienol, a HMG CoA reductase inhibitor, on monocyte-endothelial cell adhesion. J. Nutr. Sci. Vitaminol. (Tokyo), 48, 332-337, 2002.
39. Landes, N., Pfluger, P., Kluth, D., Birringer, M., Ruhl, R., Bol, G.F., Glatt, H., and Brigelius-Flohe, R.: Vitamin E activates gene expression via the pregnane X receptor. Biochem. Pharmacol., 65, 269-273, 2003.
40. Anderson, S.L., Qiu, J., and Rubin, B.Y.: Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia. Biochem. Biophys. Res. Commun., 306, 303-309, 2003.